Causes and consequences of cognitive decline in the very elderly; The 'Leiden 85-plus Study';Oorzaken en gevolgen van cognitieve achteruitgang op hoge leeftijd; De 'Leiden 85-plus Studie'

Nederlands Tijdschrift voor Geneeskunde

Volumn 148, Issue 20, 2004, Pages 979-983

  Gussekloo, J ^a   De Craen, A J M ^a   Van Exel, E ^a   Bootsma Van Der Wiel, A ^a   Westendorp, R G J ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

HIGH DENSITY LIPOPROTEIN CHOLESTEROL;

AGED; AGING; ARTICLE; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; COGNITIVE DEFECT; DAILY LIFE ACTIVITY; HUMAN; INCIDENCE; INFLAMMATION; MAJOR CLINICAL STUDY; NETHERLANDS; POPULATION RESEARCH; PREVALENCE; PROSPECTIVE STUDY; RISK ASSESSMENT;

ACTIVITIES OF DAILY LIVING; AGED; AGED, 80 AND OVER; AGING; COGNITION DISORDERS; FEMALE; FRAIL ELDERLY; HUMANS; MALE; NETHERLANDS; PREVALENCE; PROSPECTIVE STUDIES; RISK FACTORS;

EID: 2942519512     PISSN: 00282162     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (32)

1. Oeppen J, Vaupel JW. Demography. Broken limits to life expectancy. Science 2002;296:1029-31.
2. Wiel AB der, Exel E van, Craen AJM de, Gussekloo J, Lagaay AM, Knook DL, et al. A high response is not essential to prevent selection bias: results from the Leiden 85-plus Study. J Clin Epidemiol 2002;55:1119-25.
3. Houx PJ, Shepherd J, Blauw GJ, Murphy MB, Ford I, Bollen EL, et al. Testing cognitive function in elderly populations: the PROSPER study. PROspective Study of Pravastatin in the Elderly at Risk. J Neurol Neurosurg Psychiatry 2002;73:385-9.
4. Møller JT, Cluitmans P, Rasmussen LS, Houx P, Rasmussen H, Canet J, et al. Long-term postoperative cognitive dysfunction in the elderly ISPOCDI study. ISPOCD investigators. International Study of Post-Operative Cognitive Dysfunction. Lancet 1998;351:857-61.
5. Snowdon DA, Greiner LH, Mortimer JA, Riley KP, Greiner A, Markesbery WR. Brain infarction and the clinical expression of Alzheimer disease. The Nun Study. JAMA 1997;277:813-7.
6. Neuropathology Group. Medical Research Council Cognitive Function and Aging Study. Pathological correlates of late-onset dementia in multicentre, community-based population in England and Wales. Neuropathology Group of the Medical Research Council Cognitive Function and Ageing Study (MRC CFAS). Lancet 2002; 357:169-75.
7. De la Torre JC. Alzheimer's disease as a vascular disorder: nosological evidence. Stroke 2002;33:1152-62.
8. Vermeer SE, Prins ND, Heijer T den, Hofman A, Koudstaal PJ, Breteler MM. Silent brain infarcts and the risk of dementia and cognitive decline. N Engl J Med 2003;348:1215-22.
9. Leeuw FE de, Groot JC de, Oudkerk M, Witteman JC, Hofman A, Gijn J van, et al. Hypertension and cerebral white matter lesions in a prospective cohort study. Brain 2002;125:765-72.
10. Skoog I, Andreasson LA, Landahl S, Lernfelt B. A population-based study on blood pressure and brain atrophy in 85-year-olds. Hypertension 1998;32:404-9.
11. Exel E van, Gussekloo J, Houx P, Craen AJ de, Macfarlane PW, Bootsma-van der Wiel A, et al. Atherosclerosis and cognitive impairment are linked in the elderly. The Leiden 85-plus Study. Atherosclerosis 2002;165:353-9.
12. Exel E van, Craen AJ de, Gussekloo J, Houx P, Bootsma-van der Wiel A, Macfarlane PW, et al. Association between high-density lipoprotein and cognitive impairment in the oldest old. Ann Neurol 2002;51:716-21.
13. Weverling-Rijnsburger AWE, Jonkers IJAM, Exel E van, Gussekloo J, Westendorp RGJ. High-density vs low-density lipoprotein cholesterol as the risk factor for coronary artery disease and stroke in old age. Arch Intern Med 2003;163:1549-54.
14. Blake GJ, Ridker PM. C-reactive protein, subclinical atherosclerosis, and risk of cardiovascular events. Arterioscler Thromb Vasc Biol 2002;22:1512-3.
15. Libby P. Inflammation in atherosclerosis. Nature 2002;420:868-74.
16. Young JL, Libby P, Schonbeck U. Cytokines in the pathogenesis of atherosclerosis. Thromb Haemost 2002;88:554-67.
17. Rothwell N, Allan S, Toulmond S. The role of interleukin I in acute neurodegeneration and stroke: pathophysiological and therapeutic implications. J Clin Invest 1997;100:2648-52.
18. Westendorp RG, Langermans JA, Huizinga TW, Verweij CL, Sturk A. Genetic influence on cytokine production in meningococcal disease. Lancet 1997;349:1912-3.
19. Exel E van, Gussekloo J, Craen AJM de, Frolich M, Bootsma van der Wiel A, Westendorp RGJ. Inflammation and stroke: the Leiden 85-plus Study. Stroke 2002;33:1135-8.
20. Exel E van, Craen AJM de, Remarque EJ, Gussekloo J, Houx P, Bootsma-van der Wiel A, et al. Interaction of atherosclerosis and inflammation in elderly subjects with poor cognitive function. Neurology 2003;61:1695-701.
21. Exel E van. Impact of atherosclerosis and inflammation on cognitive function. The Leiden 85-plus Study [proefschrift]. Leiden: Universiteit Leiden; 2000.
22. Bootsma-van der Wiel A. Disability in the oldest old. The Leiden 85-plus Study [proefschrift]. Leiden: Universiteit Leiden; 2002.
23. Faber M von, Bootsma-van der Wiel A, Exel E van, Gussekloo J, Lagaay AM, Dongen E van, et al. Successful aging in the oldest old. Who can be characterized as successfully aged? Arch Intern Med 2001;161:2694-700.
24. Faber M von. Maten van succes bij ouderen. De Leiden 85-plus Studie [proefschrift]. Amsterdam: Universiteit van Amsterdam; 2002.
25. Veld BA in't, Ruitenberg A, Hofman A, Launer LJ, Duijn CM van, Stijnen T, et al. Nonsteroidal antiinflammatory drugs and the risk of Alzheimer's disease. N Engl J Med 2001;345:1515-21.
26. Weggen S, Eriksen JL, Das P, Sagi SA, Wang R, Pietrzik CU, et al. A subset of NSAIDs lower amyloidogenic Abeta42 independently of cyclooxygenase activity. Nature 2001;414:212-6.
27. Ritchie K, Lovestone S. The dementias. Lancet 2002;360:1759-66.
28. Morgan D, Diamond DM, Gottschall PE, Ugen KE, Dickey C, Hardy J, et al. A beta peptide vaccination prevents memory loss in an animal model of Alzheimer's disease. Nature 2000;408:982-5.
29. Furlan R, Brambilla E, Sanvito F, Roccatagliata L, Olivieri S, Bergami A, et al. Vaccination with amyloid-beta peptide induces autoimmune encephalomyelitis in C57/BL6 mice. Brain 2003;126 (Pt 2):285-91.
30. Forette F, Seux ML, Staessen JA, Thijs L, Babarskiene MR, Babeanu S, et al. The prevention of dementia with antihypertensive treatment: new evidence from the Systolic Hypertension in Europe (Syst-Eur) study. Arch Intern Med 2002;162:2046-52.
31. Skoog I, Gustafson D. Hypertension and related factors in the etiology of Alzheimer's disease. Ann N Y Acad Sci 2002;977: 29-36.
32. Shepherd J, Blauw GJ, Murphy MB, Bollen EL, Buckley BM, Cobbe SM, et al. Pravastatin in elderly individuals at risk of vascular disease (PROSPER): a randomised controlled trial. Lancet 2002; 360:1623-30.